Recent Promotions
TNKS Knockout HEK293 Cell Line
Cat.No.:
EDJ-KQ6320
Species:
Human
Cell Name:
HEK293
Gene:
TNKS
Gene ID:
8658
Size:
1×10⁶cells
TNKS Knockout Cell Line (HEK293) is an exclusive upgraded CRISPR/Cas9 system-mediated gene knockout cell, with the advantages of Optimized Strategy Design, Efficient Cell Transfection, High-Performance Cas9 Protein and Hassle-Free Cell Selection.
| Cat.No. | EDJ-KQ6320 |
|---|---|
| Product Name | TNKS Knockout Cell Line(HEK 293) |
| Cell Line | HEK293 |
| Cellosaurus ID | CVCL_0045 |
| Cell Line Synonyms | Hek293, HEK-293, HEK/293, (HEK)293, HEK 293, HEK,293, 293, 293 HEK, 293 Ad5, Graham 293, Graham-293, Human Embryonic Kidney 293 |
| Gene | |
| NCBI Gene ID | |
| Gene Synonyms | ARTD5|PARP-5a|PARP5A|PARPL|TIN1|TINF1|TNKS1|pART5 |
| Summary |
Enables histone binding activity; pentosyltransferase activity; and zinc ion binding activity. Involved in several processes, including positive regulation of canonical Wnt signaling pathway; post-translational protein modification; and regulation of chromosome organization. Acts upstream of or within peptidyl-serine phosphorylation and peptidyl-threonine phosphorylation. Located in several cellular components, including chromosome, telomeric region; mitotic spindle pole; and nucleus. [provided by Alliance of Genome Resources, Jul 2025]
|
| Associated Diseases | Non-tumor |
| Morphology | Adherent |
| Passage Ratio | 1/5,2days |
| Complete Culture Medium | DMEM + 10% FBS |
| Freezing Medium | 95% Complete culture medium+ 5% DMSO |
| QC | Indels validated by Sanger sequencing; sterility confirmed via microbial testing. |
* For research use only. Not intended for use in humans or animals, including clinical, therapeutic, or diagnostic purposes.
| Loci | STR Info (Sample Cell) Sample Cell Line: HEK293 | STR Info (Cell bank) Cell Line: HEK293 | ||
| Allele1 | Allele2 | Allele1 | Allele2 | |
| Amelogenin | X | X | ||
| CSF1P0 | 12 | 11 | 12 | |
| D2S1338 | 19 | 19 | ||
| D3S1358 | 15 | 17 | 15 | 17 |
| D5S818 | 8 | 8 | 9 | |
| D7S820 | 11 | 12 | 11 | 12 |
| D8S1179 | 12 | 14 | 12 | 14 |
| D13S317 | 12 | 14 | 12 | 14 |
| D16S539 | 9 | 13 | 9 | 13 |
| D18S51 | 17 | 18 | 17 | 18 |
| D19S433 | 15 | 18 | 15 | 18 |
| D21S11 | 28 | 30.2 | 28 | 30.2 |
| FGA | 23 | 23 | ||
| Penta D | 9 | 10 | 9 | 10 |
| Penta E | 7 | 15 | 7 | 15 |
| TH01 | 7 | 9.3 | 7 | 9.3 |
| TPOX | 11 | 11 | ||
| vWA | 16 | 19 | 16 | 19 |
| D6S1043 | 11 | 11 | ||
| D12S391 | 19 | 21 | 11 | 15 |
| D2S441 | 11 | 15 | 11 | 15 |
* STR authentication data of this cell line matches with that of cell lines sourced from ATCC, DSMZ, JCRB, and RIKEN databases.
Conclusion: The STR identification of this cell is correct.
Conclusion: The STR identification of this cell is correct.
* Research Use Disclaimer: Content is generated from publicly available research data, bioinformatic resources, and computational analyses for research reference only.
Research Publications
Tankyrases positively regulate influenza A virus replication via type I interferon response.
IF=3.8
Journal of virology
Influenza viruses are respiratory pathogens that cause both seasonal and unpredictable pandemic infections in humans. Currently approved anti-influenza drugs target the viral proteins. A recurrent mutation in the influenza genome leads to drug resistance and thus hinders the efficacy of anti-influenza drug treatments. Influenza A virus (IAV) depends on host factors to complete its virus life cycle. Thus, there are increasing interests in antiviral drugs that target host cellular proteins required for virus replication. Poly (ADP-ribose) polymerases (PARPs) are the host factors that modify protein functions by adding ADP-ribose to target proteins. Using the CRISPR activation system, we screened all 17 PARP members for its effects on IAV infection in lung epithelial A549 cells. Tankyrase 1 and 2 (TNKS 1/2 or PARP5A/5B) were found to be potent proviral factors. Knockout of TNKS1 or TNKS2 in HEK293T cells by CRISPR reduced viral mRNA and protein levels in cells and viral titers in culture media. Double knockout of TNKS1 and TNKS2 had a larger effect on IAV infection than single knockout of each isoform. The effect of TNKS double knockout on IAV replication was strain independent. Overexpression of TNKS1/2 in the double knockout cells restored the IAV replication to a level similar to the control cells. TNKS double knockout activated JNK/c-Jun signaling, enhanced Stat signaling, and increased type I interferon expression. Finally, or KO mice challenged with a sublethal IAV showed increased type I IFN response and reduced viral load in the lungs. The survival rate of or KO mice from a lethal IAV infection was significantly increased compared to wild-type mice. In conclusion, TNKS1 and TNKS2 regulate influenza virus infection via type I interferon response.IMPORTANCEPoly (ADP-ribose) polymerases (PARPs) play a crucial role in DNA repair, cellular stress responses, epigenetics, gene transcription, and viral infections. However, the specific roles of PARPs in influenza A virus (IAV) infection remain unclear. In this study, we identified Tankyrase 1 and 2 (TNKS1/2 or PARP5a/5b) as the potent proviral factors. Knockout of TNKS1 or TNKS2 reduced viral replication , with the double knockout showing an even greater effect. TNKS double knockout also resulted in an increased type I interferon response to IAV infection. , Tnks1 or Tnks2 KO mice exhibited lower viral loads and higher survival rates following IAV challenge. Our findings highlight TNKS1/2 as important regulators of IAV infection and potential targets for antiviral therapies.
This KO model may be useful for:
- Investigating the role of tankyrases in viral replication, particularly influenza A virus
- Studying the regulation of type I interferon signaling pathways
- Screening antiviral compounds targeting TNKS-dependent mechanisms
- Exploring host-virus interaction and innate immune evasion strategies
- Functional validation of TNKS in immune response modulation